Coya Therapeutics, Inc. (COYA)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 12:10PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 122.80M |
| Enterprise Value | 138.63M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 14.24 |
| Price/Book (mrq) | 3.45 |
| Enterprise Value/Revenue | 23.10 |
| Enterprise Value/EBITDA | -18.91 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change 3 | 82.03% |
| S&P500 52-Week Change 3 | 22.64% |
| 52 Week High 3 | 10.69 |
| 52 Week Low 3 | 3.21 |
| 50-Day Moving Average 3 | 9.09 |
| 200-Day Moving Average 3 | 6.09 |
Share Statistics
| Avg Vol (3 month) 3 | 98.35k |
| Avg Vol (10 day) 3 | 58.44k |
| Shares Outstanding 5 | 14.6M |
| Implied Shares Outstanding 6 | 14.6M |
| Float 8 | 9.97M |
| % Held by Insiders 1 | 7.95% |
| % Held by Institutions 1 | 18.32% |
| Shares Short (Apr 15, 2024) 4 | 184.59k |
| Short Ratio (Apr 15, 2024) 4 | 1.54 |
| Short % of Float (Apr 15, 2024) 4 | 1.37% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 1.26% |
| Shares Short (prior month Mar 15, 2024) 4 | 46.71k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -133.08% |
| Operating Margin (ttm) | 33.46% |
Management Effectiveness
| Return on Assets (ttm) | -18.53% |
| Return on Equity (ttm) | -58.64% |
Income Statement
| Revenue (ttm) | 6M |
| Revenue Per Share (ttm) | 0.59 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -7.33M |
| Net Income Avi to Common (ttm) | -7.99M |
| Diluted EPS (ttm) | -0.79 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 32.63M |
| Total Cash Per Share (mrq) | 2.24 |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 8.15 |
| Book Value Per Share (mrq) | 2.47 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -11.19M |
| Levered Free Cash Flow (ttm) | -10.33M |
© 2024 Yahoo. All rights reserved.